May 01, 2017 - Volume 75 - Issue 1 - Contributor Index

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Lacombe, Karine; Fontaine, Hélène; Dhiver, Catherine; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(1):97-107, May 01, 2017.

High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection

Kessing, Cari F.; Spudich, Serena; Valcour, Victor; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(1):108-117, May 01, 2017.

The Second-Generation Maturation Inhibitor GSK3532795 Maintains Potent Activity Toward HIV Protease Inhibitor–Resistant Clinical Isolates

Ray, Neelanjana; Li, Tianbo; Lin, Zeyu; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(1):52-60, May 01, 2017.

Neutralizing and Targeting Properties of a New Set of α4β7-Specific Antibodies Are Influenced by Their Isotype

Girard, Alexandre; Jelicic, Katija; Van Ryk, Don; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(1):118-127, May 01, 2017.

Neutralizing and Targeting Properties of a New Set of α4β7-Specific Antibodies Are Influenced by Their Isotype

Girard, Alexandre; Jelicic, Katija; Van Ryk, Don; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(1):118-127, May 01, 2017.

Author:
Violari, Avy MD

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults

Gallant, Joel E.; Thompson, Melanie; DeJesus, Edwin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 75(1):61-66, May 01, 2017.